These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26316152)

  • 41. Structure-activity relationship study of vitamin D analogs with oxolane group in their side chain.
    Belorusova AY; Martínez A; Gándara Z; Gómez G; Fall Y; Rochel N
    Eur J Med Chem; 2017 Jul; 134():86-96. PubMed ID: 28399453
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Methyl-introduced A-ring analogues of 1alpha,25-dihydroxyvitamin D3: synthesis and biological evaluation.
    Fujishima T; Tsutsumi R; Negishi Y; Fujii S; Takayama H; Kittaka A; Kurihara M
    Anticancer Res; 2006; 26(4A):2633-6. PubMed ID: 16886673
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New derivatives of 1alpha,25-dihydroxy-19-norvitamin D3 with two substituents at C-2: synthesis and biological activity.
    Shimizu M; Iwasaki Y; Shimazaki M; Amano Y; Yamamoto K; Reischl W; Yamada S
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1451-5. PubMed ID: 15713405
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 2-Methylene analogs of 1alpha-hydroxy-19-norvitamin D3: synthesis, biological activities and docking to the ligand binding domain of the rat vitamin D receptor.
    Grzywacz P; Plum LA; Sicinska W; Sicinski RR; Prahl JM; DeLuca HF
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):13-7. PubMed ID: 15225739
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A novel immunosuppressive 1alpha,25-dihydroxyvitamin D3 analog with reduced hypercalcemic activity.
    Zügel U; Steinmeyer A; Giesen C; Asadullah K
    J Invest Dermatol; 2002 Dec; 119(6):1434-42. PubMed ID: 12485451
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New 1alpha,25-dihydroxy-19-norvitamin D3 analogs with a frozen A-ring conformation.
    Glebocka A; Sicinski RR; Plum LA; DeLuca HF
    J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):46-50. PubMed ID: 20214980
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
    Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF
    Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sequential hydroxylation of vitamin D2 by a genetically engineered CYP105A1.
    Hayashi K; Yasuda K; Yogo Y; Takita T; Yasukawa K; Ohta M; Kamakura M; Ikushiro S; Sakaki T
    Biochem Biophys Res Commun; 2016 May; 473(4):853-858. PubMed ID: 27037023
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Direct C-1 hydroxylation of vitamin D compounds: convenient preparation of 1alpha-hydroxyvitamin D3, 1alpha, 25-dihydroxyvitamin D3, and 1alpha-hydroxyvitamin D2.
    Paaren HE; Hamer DE; Schnoes HK; DeLuca HF
    Proc Natl Acad Sci U S A; 1978 May; 75(5):2080-1. PubMed ID: 209448
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Total synthesis of 1α,25-dihydroxyvitamin D
    López-Pérez B; Maestro MA; Mouriño A
    Org Biomol Chem; 2018 Jun; 16(24):4563-4569. PubMed ID: 29881848
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 13-Methyl-substituted des-C,D analogs of (20S)-1alpha,25-dihydroxy-2-methylene-19-norvitamin D3 (2MD): synthesis and biological evaluation.
    Plonska-Ocypa K; Sicinski RR; Plum LA; Grzywacz P; Frelek J; Clagett-Dame M; DeLuca HF
    Bioorg Med Chem; 2009 Feb; 17(4):1747-63. PubMed ID: 19167893
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis of all possible A-ring diastereomers at the 1- and 3-positions of 1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)vitamin D3 (ED-71) using C2-symmetrical epoxide as a common starting material.
    Kubodera N; Hatakeyama S
    Anticancer Res; 2009 Sep; 29(9):3571-8. PubMed ID: 19667150
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis of (10Z)- and (10E)-19-fluoro-1alpha,25-dihydroxyvitamin D3: compounds to probe vitamin D conformation in receptor complex by 19F-NMR.
    Shimizu M; Iwasaki Y; Ohno A; Yamada S
    Chem Pharm Bull (Tokyo); 2000 Oct; 48(10):1484-93. PubMed ID: 11045456
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Design and synthesis of tetraol derivatives of 1,12-dicarba-closo-dodecaborane as non-secosteroidal vitamin D analogs.
    Fujii S; Kano A; Masuno H; Songkram C; Kawachi E; Hirano T; Tanatani A; Kagechika H
    Bioorg Med Chem Lett; 2014 Sep; 24(18):4515-4519. PubMed ID: 25149512
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vitamin D analogs as therapeutic agents: a clinical study update.
    Wu-Wong JR; Tian J; Goltzman D
    Curr Opin Investig Drugs; 2004 Mar; 5(3):320-6. PubMed ID: 15083599
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential effects of Vitamin D analogs on bone formation and resorption.
    Nakane M; Fey TA; Dixon DB; Ma J; Brune ME; Li YC; Wu-Wong JR
    J Steroid Biochem Mol Biol; 2006 Jan; 98(1):72-7. PubMed ID: 16242929
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biological Evaluation of Double Point Modified Analogues of 1,25-Dihydroxyvitamin D₂ as Potential Anti-Leukemic Agents.
    Corcoran A; Nadkarni S; Yasuda K; Sakaki T; Brown G; Kutner A; Marcinkowska E
    Int J Mol Sci; 2016 Feb; 17(2):. PubMed ID: 26840307
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Practical synthesis and evaluation of the biological activities of 1alpha,25-dihydroxyvitamin D3 antagonists, 1alpha,25-dihydroxyvitamin D3-26,23-lactams. Designed on the basis of the helix 12-folding inhibition hypothesis.
    Nakano Y; Kato Y; Imai K; Ochiai E; Namekawa J; Ishizuka S; Takenouchi K; Tanatani A; Hashimoto Y; Nagasawa K
    J Med Chem; 2006 Apr; 49(8):2398-406. PubMed ID: 16610783
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis of 1alpha,25-dihydroxyvitamin D3-26,23-lactams (DLAMs), a novel series of 1 alpha,25-dihydroxyvitamin D3 antagonist.
    Kato Y; Nakano Y; Sano H; Tanatani A; Kobayashi H; Shimazawa R; Koshino H; Hashimoto Y; Nagasawa K
    Bioorg Med Chem Lett; 2004 May; 14(10):2579-83. PubMed ID: 15109656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.